某院静脉用药不合理医嘱分析

doi:10.19803/j.1672-8629.2020.10.19

中国药物警戒 ›› 2020, Vol. 17 ›› Issue (10): 735-739.
DOI: 10.19803/j.1672-8629.2020.10.19

某院静脉用药不合理医嘱分析

刘剑¹, 李永辉², 路明¹, 张媛¹

¹河北医科大学第二医院药学部,河北石家庄050000;
²河北省药品监测评价中心,河北石家庄 050000

收稿日期:2020-10-14 修回日期:2020-10-14 出版日期:2020-10-15 发布日期:2020-10-13
作者简介:刘剑,男,硕士,副主任药师,药物体内相互作用及药学相关研究。

Analysis of Irrational Medical Advices in Pharmacy Intravenous Admixture Service in A Hospital

LIU Jian¹, LI Yonghui², LU Ming¹, ZHANG Yuan¹

¹Department of Pharmacy, the Second Hospital of Hebei Medical University, Shijiazhuang Heibei 050000, China;
²Hebei Drug Monitoring and Evaluation Center, Shijiazhuang Heibei 050000, China

Received:2020-10-14 Revised:2020-10-14 Online:2020-10-15 Published:2020-10-13

摘要/Abstract

摘要： 目的对医院静脉用药集中调配中心（PIVAS）审核干预的不合理医嘱进行统计分析,为临床用药的合理性、安全性和有效性提供有效参考。方法将2017~2018年医院静脉用药集中调配中心667 705组医嘱数据进行统计,对其中不合理医嘱进行归纳、整理和分析。结果不合理医嘱共16 180组,占总医嘱的2.42%。主要为医嘱开具错误、溶媒品种选择不当、药品使用剂量不当、全胃肠外营养配方问题、溶媒用量不当、药物不宜配伍、药品使用频次不当、成分配伍禁忌、重复用药、药品使用途径不当。结论 PIVAS审方药师通过审核医嘱,能及时介入不合理医嘱并进行干预,降低临床静脉给药不良反应的发生率,保证患者用药合理性和安全性。

关键词: 静脉用药集中调配, 不合理医嘱, 合理用药

Abstract: Objective To statistically analyze the improper prescriptions detected by the pharmacy intravenous admixture service of the Second Hospital of Hebei Medical University between 2017 and 2018 so as to provide reference for the rationality, safety and effectiveness of clinical medication. Methods The data on 667705 medical prescriptions were classified and collected from the pharmacy intravenous admixture service of The Second Hospital of Hebei Medical University from 2017 to 2018. To sum up, sort out and analyze the irrational medical advice. Results There were 16 180 irrational medical advices, accounting for 2.42% of the total medical advices. The irrational factors included wrong Format of Doctor's Order, improper selection of solvent varieties, inappropriate dosage of drugs, TPN inappropriate formula, improper dosage of solvent, nappropriate compatibility of drugs, improper frequency of drug use, incompatibility of drugs in a prescription, repeated medication, incorrect use of drugs. Conclusion Irrational medical prescriptions can be found and intervened in time by examination of prescriptions of pharmacists, which not only can reduce the incidence of intravenous administration clinical adverse reactions, but also ensure the rationality and safety of patient's medication, promoting the specialization of patient drug use.

Key words: pharmacy intravenous admixture service, irrational medical prescriptions, rational use of drugs.

中图分类号:

R969.3

刘剑, 李永辉, 路明, 张媛. 某院静脉用药不合理医嘱分析[J]. 中国药物警戒, 2020, 17(10): 735-739.

LIU Jian, LI Yonghui, LU Ming, ZHANG Yuan. Analysis of Irrational Medical Advices in Pharmacy Intravenous Admixture Service in A Hospital[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 735-739.

参考文献

[1] Liu XC,Gao HQ.Pharmacy intravenous admixture service and intravenous drug therapy(静脉药物配置中心与静脉药物治疗)[M]. Beijing: People's Medical Publishing House,2006:12.
[2] Wu YP,Jiao YH.Guidelines for the allocation and use of intravenous medication in clinic(临床静脉用药调配与使用指南)[M]. Beijing: People's Medical Publishing House,2010: 5.
[3] Ministry of Health, PRC. Standard for quality Control of pharmacy intravenous admixture service(静脉用药集中调配质量管理规范)[M]. People's Medical Publishing House,2010:6.
[4] Ji WJ,Liu JJ,Qian S,et al.Analysis of unreasonable doctor's orders in pharmacy intravenous admixture service of a third-grade A hospital[J]. China's health industry(中国卫生产业),2018,15(25):94-99.
[5] Lu M,Zhang GF,Xie D,et al.Analysis of 548 unreasonable doctor's orders for drug use in pharmacy intravenous admixture service[J]. Contemporary Chinese Medicine(中国当代医药), 2018,25(26): 147-151.
[6] Guan DY,Zhao MX,Yang YH, et al.Analysis of doctor's orders for total parenteral nutrition based on TPN audit system[J]. Practical medicine and clinic(实用药物与临床), 2018,21(12):1443-1446.
[7] Zhang ZQ,Liu BL,Zhang JZ.Assessment guidance of post skill for hospital pharmacist(医院药师岗位技能考核辅导)[M]. Beijing: Chemical Industry Press, 2014:126.
[8] Yuan F.Analysis of unreasonable doctor's orders in pharmacy intravenous admixture service in a hospital of 2017[J]. Journal of Traditional Chinese Medicine Management(中医药管理杂志), 2018,26(22):28-33.
[9] Xing ZJ,Jiang HX,Zhong HL, etc. Analysis of unreasonable doctor's orders in pharmacy intravenous admixture service in our hospital[J]. Medicine today(今日药学), 2017,27(2):131-133.
[10] Cao JH,Zhao RK.Analysis of 3 279 unreasonable doctor's orders for drug use in pharmacy intravenous admixture service[J]. Evaluation and analysis of drug use in Chinese hospitals(中国医院用药评价与分析), 2017,17(5):673-675.
[11] Tian PY,Liu L,Xiang ZY.Analysis of 16 300 unreasonable doctor's orders in pharmacy intravenous admixture service in our hospital[J]. China's exploration of rational drug use(中国合理用药探索), 2017,14(2):41-44.
[12] Lu J,Zhen JC.Analysis of medical advice review of oral drugs for inpatients in our hospital from 2013 to 2016[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2017,14(2):113-115.
[13] Renaudin P, Boyer L,Esteve MA, etc. Do pharmacist-led medication reviews in hospitals help reduce hospital readmissions? A systematic review and meta-analysis[J]. Br J ClinPharmacol, 2016,82(6): 1660-1673.
[14] Sun YT,Zhang GY,Qian XP.Analysis of 193 unreasonable doctor's orders for intravenous drug use in central pharmacy[J]. Evaluation and analysis of drug use in Chinese hospitals(中国医院用药评价与分析), 2018,18(10):1412-1414.
[15] Zhang X,Niu J,Wu X Y, etc. Pareto diagram analysis of unreasonable drug prescription in pharmacy intravenous admixture service in our hospital[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2017,14(3):183-185.

某院静脉用药不合理医嘱分析

Analysis of Irrational Medical Advices in Pharmacy Intravenous Admixture Service in A Hospital

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	范凯凯, 王聪, 刘洪峰, 王西勇. 临床药师对某院丙氨酰谷氨酰胺注射液应用干预分析[J]. 中国药物警戒, 2024, 21(2): 181-184.
[2]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[3]	黎杏仁, 沈爱宗, 苏丹. 质子泵抑制剂预防胆胰外科围术期应激性黏膜病变的合理性评价[J]. 中国药物警戒, 2023, 20(9): 1022-1026.
[4]	史香芬, 孙志勇, 张旭锋, 卢晓静, 杜书章, 张晓坚. 基于智能信息管理系统的门诊麻精药品全流程管理[J]. 中国药物警戒, 2023, 20(8): 899-903.
[5]	霍艳飞, 田月洁, 许莉莉, 谢彦军, 常虹, 孙春晓, 李霞. 535例氢溴酸高乌甲素制剂新的和严重的药品不良反应报告分析[J]. 中国药物警戒, 2023, 20(8): 921-926.
[6]	刘婧, 夏亮, 张世杰. 1例多元药物过敏急性胰腺炎患者行药物激发试验的药学监护[J]. 中国药物警戒, 2023, 20(7): 822-824.
[7]	范秀丛, 董晓慧, 陈丹霞, 鲍思蔚, 马雅斌. 1例妊娠期艰难梭菌感染伴尿路感染患者的药学监护[J]. 中国药物警戒, 2023, 20(5): 579-582.
[8]	殷进军, 王淑伟, 邵姜超, 王冰. 基于加权TOPSIS法的贝伐珠单抗注射液药物利用评价[J]. 中国药物警戒, 2023, 20(12): 1421-1426.
[9]	刘斌, 邵美玲, 蔡怡然, 马丰懿, 兰鸿. 戴明环循环管理在提高门诊处方合理率中的应用价值[J]. 中国药物警戒, 2022, 19(9): 1035-1039.
[10]	庄红艳, 臧彦楠, 刘珊珊, 牛梦溪, 房萌, 尹冬青, 果伟. 唑吡坦致神经精神系统不良反应分析[J]. 中国药物警戒, 2022, 19(8): 889-892.
[11]	马冰冰, 张晓朦, 张冰, 林志健, 吕锦涛. 基于文献分析的老年人中成药合理用药与药学服务思考[J]. 中国药物警戒, 2022, 19(6): 595-599.
[12]	李晓菲, 程蓉, 吴雪梅, 刘智. 注射用特利加压素的安全性分析[J]. 中国药物警戒, 2022, 19(6): 654-656.
[13]	陈方方, 张红旭. 大剂量甲氨蝶呤治疗原发性中枢神经系统淋巴瘤的药学实践[J]. 中国药物警戒, 2022, 19(4): 446-449.
[14]	靳浩槟, 郑磊, 杨静, 管玉瑶, 张晓丽. 住院患者皮肤药品不良反应及伴随的肝肾功能异常分析[J]. 中国药物警戒, 2022, 19(3): 310-312.
[15]	徐喆, 鞠萍, 罗琪, 杨欢, 汪洋. 930例儿童抗菌药物不良反应分析[J]. 中国药物警戒, 2022, 19(3): 317-321.